The conference will bring to you key speakers across the industry sharing insights on the changing PV landscape, expanding the vistas of drug safety enhancement of healthcare, outcomes, and treatment efficacy ushering in safe personalized medicines through advanced healthcare science.
Registration Link: https://bit.ly/3n3UMYO
Promotional/Referral Code: PVPHARMA23
The focus is to create insightful sessions among all stakeholders around the following themes:
Current Regulatory challenges in the medical devices (MaterioVigilance) domain & solutions
Platform augment with AI/ML in streamlining the PV landscape
Personalised medical care, and ensuring Patients’ safety through Pharmacogenomics
Cosmetovigilance: Cosmetic testing roadmap to Cosmetovigilance
Patient-centricity and patient-centric health systems
Adoption of Decentralised Clinical Trials (DCT) Management, the challenges involved & pragmatic approaches
Excellence in Medical Writing through integrated and synchronized teamwork between Pharmacovigilance, Regulatory Affairs & Medical Affairs
The learning objectives from the sessions will be:
Pharmacogenomics: The Cornerstone of Personalized Medicine
Medical Writing & Pharmacovigilance: Leveraging the synergies for benefiting patients
Science of Literature Surveillance & Technology Roadmap
Changing Landscape of Materiovigilance
PV and Covid, Expectations vs Reality
New Age Pharmacovigilance- New and Emerging Therapies and Our Readiness
PV system for improved patient safety enabled by platforms, Artificial Intelligence and Automation
Cosmetology
The keynote speakers of the event are:
Moin Don, Adjunct Prof Jamia Hamdard Delhi, Lead: South Asia Chapter (ISoP), International Society of Pharmacovigilance (ISoP), Founder & CEO PVCON Consulting, India
Ashish Indani, Sr. Manager – Clinical Affairs, Stryker , India
Fahd Khan, Director Business Development, OrciMed Life Science Private Limited, India
Prashant Joshi, RPh, Executive Director – Drug Safety, Labcorp Drug Development, India
Ritu Jaswal, Vice President- Pharmacovigilance Operations, PAREXEL, India
Saket Singh Kumar, MSc, VP Global PV Capability Lead, Accenture , India
Sonica Sachdeva Batra, DrMed, Associate Vice President, Global Delivery Head, Indegene, India
J Vijay Venkatraman, MD, MBA, Managing Director and CEO, Oviya MedSafe, India
Vijay Bhargav, Vice President, Lifecycle Safety, IQVIA, India
Shobhit Shrotriya, PMP, Managing Director, Life Sciences R&D Operations, Accenture, India
Abhijit Surwade, Global Pharmacovigilance Physician, Colgate-Palmolive, India
Gerald J. Dal Pan, MD, MHS, Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
Prashant Dhanavade, Associate Director – Patient Safety Solutions, Labcorp Drug Development, India
Brian Edwards, DrMed, Vice President, International Society of Pharmacovigilance, United Kingdom
Jeyaseelan Jeyaraj, Senior Director, Solutions Consulting, Asia Pacific, Oracle Health Sciences Global Business Unit, India
Kedar Mehta, Associate Professor, Govt. Medical College Vadodara, India
Sakshi Rastogi, Global Client Solutions Partner, Quantiphi, India
Srikanth S, MPharm, Associate Director, Head – SARA Literature center, Life Cycle Safety, IQVIA, India
Arunima Sen, MD, Associate Vice President, Product Safety and Risk Management, Viatris, India
Renu Sharma, Senior Director Pharmacovigilance Operations, Parexel, India
Mohammed Sibgatullah, Director -Medical Affairs, OrciMed Life Science Private Limited, India
Niraj Vyas, Director of Risk Management & Central Monitoring, The Janssen Pharmaceutical Companies of Johnson & Johnson, India
Anu Acharya, CEO, Mapmygenome.in, India
Vaibhav Budhiraja, Senior Manager – PV Operations, Paraxel, India
Bobby George, Ph.D., Vice President & Group Head Regulatory Affairs, Reliance Life Sciences, India
Mukesh Gori, Director –CMO&IPS, Global External Service Partner Engagement,
Pharmacovigilance & Safety Alliance Operations, Novartis, India
Sadhna Jitendra Joglekar, MD, Senior Vice President Global Medical Affairs, Novartis, India
V. Kalaiselvan, Senior Principal Scientific Officer, Indian Pharmacopoeia Commission, India
Shadab Makhdoomi, Associate Vice President, Accenture Life Sciences, India
Pravin Patil, Manger, PRMW, Global Pharmacovigilance, Innovation & Development Established, Pharmaceuticals, Abbott Healthcare Pvt Ltd, India
Geethashree Shambu, Delivery Lead – Safety Operations, Indegene Pvt Ltd, India
Thirumalai Velu Swaminathan, Director, India & South Asia-Regulatory Affairs & Pharmacovigilance, Galderma India Pvt Limited, India
Sanjay Vyas, Executive Vice President, India Country Head & Managing Director, Global SBU, Head – Safety Services & Logistics, Parexel, India
Jamal Anwar Baig, Ph.D., Multi-Country Safety Head – South Asia & Indo-China (Vietnam), Sanofi, India
Naveen Chhabra, Global Medical Safety Lead, Global Drug Development, Novartis, India
Varun Dua, Vice President -Professional Services, RxLogix, India
Dhanaraj E, Pharmacovigilance Lead- CDMA-BBL, Biocon, India
Kanchan Kanitkar, Sr. Manager and Literature SME – Patient Safety Solution, Labcorp Drug Development India Pvt Ltd. India
Ram Mudaliar, Senior Director (India CDI Lead) Clinical Data & Insights (CDI), AstraZeneca, India
John Praveen, Associate Vice President – PV Account Delivery and PV Shared Services Offering, Lead, Accenture, India
Shubha Rao, DDS, MSc, Senior Director, Pharmacovigilance and Drug Safety, Indegene Pvt Ltd, India
Omprakash Sadhwani, Joint Commissioner (Law), FDA, India
Viqar Ahmed Shah, Senior Manager – Regulatory Affairs, Mylab Discovery Solutions Pvt. Ltd., India
Chetanraj Bhamare, Safety Physician (Asst. General Manager), Clinical Research, and pharmacovigilance dept., Serum Institute of India Pvt Ltd, India
Pankajkumar Chhatrala, Founder, CEO, Orthoheal, India
Susan Korah, AVP, TCS, India
Bindu Narang, Executive Director – Patient Safety Solutions, Labcorp, India
Shatrunajay Shukla, Scientific Assistant MvPI, Indian Pharmacopoeia Commission, India
Tarunjot Singh, DDS, Director – Safety and Pharmacovigilance, Syneos Health, India
The two days conference will bring together attendees from different various domains including Pharmacovigilance and Drug Safety, Risk Management, Clinical Professionals, Medical Writing, Pharmacovigilance Compliance, Regulatory Affairs, Medical Affairs
Late Phase Professionals Conducting PMS, Observational and Non-Interventional Studies, Real World Data and Real-World Evidence, and Technology Professionals. So come and expand your knowledge of the drug safety enhancement of healthcare and strategies at this top-level conference.
REGISTER NOW!
Related Post: Exclusive Coverage: Key Takeaways from the DIA India Medical Devices Conference 2020
